West Net Working Capital vs Net Debt Analysis

WST Stock  USD 331.40  0.00  0.00%   
West Pharmaceutical financial indicator trend analysis is more than just analyzing West Pharmaceutical current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether West Pharmaceutical is a good investment. Please check the relationship between West Pharmaceutical Net Working Capital and its Net Debt accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Net Working Capital vs Net Debt

Net Working Capital vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of West Pharmaceutical Net Working Capital account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between West Pharmaceutical's Net Working Capital and Net Debt is -0.94. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Net Debt in the same time period over historical financial statements of West Pharmaceutical Services, assuming nothing else is changed. The correlation between historical values of West Pharmaceutical's Net Working Capital and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of West Pharmaceutical Services are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Net Working Capital i.e., West Pharmaceutical's Net Working Capital and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.94
Relationship DirectionNegative 
Relationship StrengthSignificant

Net Working Capital

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from West Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into West Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At this time, West Pharmaceutical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 31.87 in 2024, whereas Enterprise Value is likely to drop slightly above 252.4 M in 2024.
 2021 2022 2023 2024 (projected)
Total Revenue2.8B2.9B2.9B3.1B
Depreciation And Amortization122.3M120.6M137.3M144.2M

West Pharmaceutical fundamental ratios Correlations

0.320.860.980.980.98-0.870.970.970.980.480.970.980.670.120.990.91-0.70.760.990.65-0.350.980.940.540.54
0.320.120.290.160.30.120.110.160.40.20.170.220.560.920.260.210.090.580.210.070.720.30.110.350.35
0.860.120.870.870.82-0.850.840.90.830.560.90.880.610.010.870.77-0.50.590.890.38-0.40.890.790.580.58
0.980.290.870.960.96-0.860.960.950.960.50.950.960.650.080.980.92-0.720.760.970.7-0.330.980.930.490.5
0.980.160.870.960.97-0.930.990.980.960.440.980.990.63-0.040.990.91-0.720.660.990.65-0.50.970.960.540.55
0.980.30.820.960.97-0.830.970.930.990.320.930.960.710.10.980.91-0.710.680.960.71-0.350.960.930.580.58
-0.870.12-0.85-0.86-0.93-0.83-0.93-0.95-0.79-0.48-0.95-0.92-0.440.32-0.9-0.790.69-0.5-0.93-0.540.71-0.87-0.89-0.47-0.48
0.970.110.840.960.990.97-0.930.970.940.390.970.970.56-0.090.980.93-0.810.660.980.71-0.510.940.980.460.47
0.970.160.90.950.980.93-0.950.970.920.531.00.980.57-0.030.980.88-0.710.710.990.57-0.480.960.940.510.52
0.980.40.830.960.960.99-0.790.940.920.380.920.950.760.220.970.9-0.640.740.950.65-0.250.970.90.590.6
0.480.20.560.50.440.32-0.480.390.530.380.530.520.290.150.480.43-0.110.540.520.06-0.10.510.430.120.13
0.970.170.90.950.980.93-0.950.971.00.920.530.980.56-0.020.980.88-0.710.710.990.57-0.470.960.940.510.51
0.980.220.880.960.990.96-0.920.970.980.950.520.980.670.030.990.9-0.660.710.990.59-0.450.980.930.550.56
0.670.560.610.650.630.71-0.440.560.570.760.290.560.670.430.670.57-0.060.420.620.30.020.720.480.750.76
0.120.920.010.08-0.040.10.32-0.09-0.030.220.15-0.020.030.430.070.030.260.480.02-0.210.840.1-0.090.170.16
0.990.260.870.980.990.98-0.90.980.980.970.480.980.990.670.070.91-0.70.720.990.64-0.40.980.950.550.55
0.910.210.770.920.910.91-0.790.930.880.90.430.880.90.570.030.91-0.810.730.910.73-0.340.870.950.320.33
-0.70.09-0.5-0.72-0.72-0.710.69-0.81-0.71-0.64-0.11-0.71-0.66-0.060.26-0.7-0.81-0.57-0.71-0.780.45-0.62-0.850.020.01
0.760.580.590.760.660.68-0.50.660.710.740.540.710.710.420.480.720.73-0.570.730.380.130.720.670.150.16
0.990.210.890.970.990.96-0.930.980.990.950.520.990.990.620.020.990.91-0.710.730.61-0.440.970.950.520.53
0.650.070.380.70.650.71-0.540.710.570.650.060.570.590.3-0.210.640.73-0.780.380.61-0.330.610.740.140.15
-0.350.72-0.4-0.33-0.5-0.350.71-0.51-0.48-0.25-0.1-0.47-0.450.020.84-0.4-0.340.450.13-0.44-0.33-0.37-0.49-0.16-0.16
0.980.30.890.980.970.96-0.870.940.960.970.510.960.980.720.10.980.87-0.620.720.970.61-0.370.90.590.6
0.940.110.790.930.960.93-0.890.980.940.90.430.940.930.48-0.090.950.95-0.850.670.950.74-0.490.90.370.38
0.540.350.580.490.540.58-0.470.460.510.590.120.510.550.750.170.550.320.020.150.520.14-0.160.590.371.0
0.540.350.580.50.550.58-0.480.470.520.60.130.510.560.760.160.550.330.010.160.530.15-0.160.60.381.0
Click cells to compare fundamentals

West Pharmaceutical Account Relationship Matchups

West Pharmaceutical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.3B2.8B3.3B3.6B3.8B4.0B
Short Long Term Debt Total329.3M325.7M325.3M317.9M309M230.5M
Other Current Liab145.4M175.4M211.1M173.6M187.3M196.7M
Total Current Liabilities341.6M503.4M594.1M519M671.8M705.4M
Total Stockholder Equity1.6B1.9B2.3B2.7B2.9B3.0B
Property Plant And Equipment Net909.4M1.0B1.1B1.3B1.5B1.6B
Net Debt(109.8M)(289.8M)(437.3M)(576.4M)(544.9M)(517.7M)
Retained Earnings1.5B1.8B2.5B3.0B3.5B3.7B
Cash439.1M615.5M762.6M894.3M853.9M896.6M
Non Current Assets Total1.3B1.4B1.6B1.7B1.9B2.0B
Non Currrent Assets Other20.5M29M36.3M55.9M38.4M32.0M
Cash And Short Term Investments439.1M615.5M762.6M894.3M853.9M896.6M
Net Receivables319.3M385.3M489M507.4M512M537.6M
Liabilities And Stockholders Equity2.3B2.8B3.3B3.6B3.8B4.0B
Non Current Liabilities Total426.6M435.9M384.3M412.9M276.7M307.8M
Inventory235.7M321.3M378.4M414.8M434.7M456.4M
Other Current Assets64.6M51.6M112M103M135.8M142.6M
Other Stockholder Equity154.6M99.6M19.5M(138.7M)(517.4M)(491.5M)
Total Liab768.2M939.3M978.4M931.9M948.5M995.9M
Total Current Assets1.1B1.4B1.7B1.9B1.9B2.0B
Short Term Debt11.9M22.5M62.8M34.2M169.4M177.9M
Intangible Assets29.8M30.5M23M18.4M15.1M14.3M
Accounts Payable156.8M213.1M232.2M215.4M242.4M254.5M
Property Plant And Equipment Gross909.4M1.0B2.2B2.4B2.8B3.0B
Accumulated Other Comprehensive Income(149.6M)(110.6M)(159.6M)(183M)(143.8M)(151.0M)
Other Liab109.2M117M112.5M113.2M130.2M107.9M
Other Assets43M52.3M104.4M104M93.6M47.0M
Long Term Debt255M252.9M208.8M206.7M72.8M69.2M
Good Will107.8M111.1M109.9M107.3M108.5M103.1M
Treasury Stock(118.1M)(167.7M)(229.5M)(370.9M)(333.8M)(317.1M)
Property Plant Equipment839.3M943.2M1.1B1.2B1.3B1.4B
Current Deferred Revenue27.5M51M48.7M57.3M41.7M38.2M
Net Tangible Assets1.4B1.7B2.1B2.6B2.9B3.1B
Retained Earnings Total Equity1.5B1.8B2.5B3.0B3.4B3.6B
Long Term Debt Total255M252.9M208.8M206.7M186.0M209.4M
Capital Surpluse272.7M267.3M249M232.2M267.0M223.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.